glucagon like peptide 1 glp 1 Glucagon-like peptide-1 receptor co-agonists for treating metabolic disease Glucagon-like peptide 1 molecule, illustration
Description
This dual action can lead to even greater weight loss and metabolic benefits for certain patients
The large, randomized trials that have been done with GLP-1 receptor agonists versus placebo show no signal for pancreatitis
In this class, we're seeing less of the big three heart outcomes, which is heart attack, stroke, and cardiovascular death
Completing an evaluation does not guarantee that a prescription will be provided
